Nov 11, 2026
771:649
For every 649 shares held, investors received 771. The price per share adjusted from $1865.20 to $1570.06.
The split itself did not change the total investment value.
Evonile Pharma Limited (NSE:EVONILE) operates in the Pharmaceuticals: major industry.
Evonile Pharma Limited company overviewEvonile Pharma Limited's most recent stock split was on November 11, 2026. It was a 771-for-649 forward split, so shareholders received 771 shares for every 649 they held.
Evonile Pharma Limited (NSE:EVONILE) has split its stock 3 times: a 10-for-1 split on October 21, 1997, a 10-for-1 split on December 30, 1997, and a 771-for-649 split on November 11, 2026.
Evonile Pharma Limited has split its stock 3 times. This history records 3 forward splits between October 21, 1997 and November 11, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Evonile Pharma Limited's 771-for-649 split on November 11, 2026, every 649 shares became 771 shares.
Evonile Pharma Limited has not announced a new split in our records. Its most recent split was on November 11, 2026, less than a year ago. Companies announce splits in advance, and any new NSE:EVONILE split will appear on this page.
Already premium?